About this trial
Premature babies often require breathing support during their neonatal intensive care unit stay. This is because their lungs are not fully developed to perform the work of breathing on their own. Although breathing support can be provided via a breathing tube, it is preferable to provide breathing support non-invasively from a breathing machine which is then connected to a mask or prongs placed on the baby's nose. In premature babies born under 32 weeks gestation, a commonly used mode of non-invasive breathing support is called Non-Invasive Positive Pressure Ventilation (NIPPV). In this mode, the breathing machine provides 2 levels of support: one is the constant distending pressure to keep the lungs open and the other provides additional 'breaths' on top of that distending pressure. This is to mimic regular breathing. These breaths are set at a fixed rate and pressure. Although NIPPV protects the lungs from injury caused by a breathing tube, the breaths are not in sync with the baby's own breathing effort. Another mode of non-invasive breathing support recently being used in premature infants called Neurally Adjusted Ventilatory Assist (NAVA). When NAVA is provided non-invasively using a mask or prongs similar to NIPPV, it is called Non-invasive NAVA (NIV-NAVA). During NIV-NAVA a special feeding tube is used that detects the baby's own breathing movement from the electrical signal of the baby's diaphragm and feeds back to the machine which then provides a 'top-up' to the baby's own breath. This top-up breath also provides only as much pressure as the baby needs on top on their own breathing effort. Therefore, this is thought to be in sync with the baby's own breathing effort. However, it is not known if this mode of ventilation leads to improved sleep, improved brain oxygen levels, reduced discomfort and improved functioning of the diaphragm. The investigators aim to examine these indices in this research project.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Preterm infants born between 22+0 and 31+6 weeks' GA
Weight > 500 g at the time of approach for consent
A minimum of 3 days of age
Clinically stable for > 24 hours while receiving NIPPV or NIV-NAVA
Disqualifiers
Infants with IVH of grade 3 or 4
Birth weight < 3rd percentile
Genetic or congenital abnormalities
Trial population
Preterm infants at tertiary NICU at Mount Sinai Hospital (Toronto, Ontario).
Trial design
Case-crossover
Prospective
Treatments tested in this trial
Non-invasive Neurally Adjusted Ventilatory Assist
DeviceNeurally Adjusted Ventilatory Assist (NAVA) is a new non-invasive ventilation mode that uses the electrical activity of the diaphragm (EAdi) to offer ventilatory assistance in synchrony with patient effort, thus potentially reducing stress and discomfort. It uses electrodes placed on a modified nasogastric feeding tube to detect the electrical activity of the diaphragm (EAdi), such that both the initiation and termination of a breath during each respiratory cycle is in synchrony with the infant's effort
Treatment groups
Trial outcomes
Primary outcomes
Number of uninterrupted sleep-wake cycling (SWC)
An uninterrupted SWC will be defined as a smooth and gradual decrease in the minimum amplitude on aEEG to quiet sleep (QS), followed by a gradual increase to active sleep or awake state (AS). An interrupted SWC will be defined as a sudden or sharp increase in the minimum amplitude during QS with change to AS state that may or may not be followed by a further drop in QS.
Secondary outcomes
Total duration of quiet sleep (QS)
First, high base voltage (HBV) will be defined as the voltage of the lower margin of aEEG during AS. Total QS duration will be calculated as the combined duration of time spent below the HBV in uninterrupted SWC during 24 h.
Cerebral oxygen saturation (CrSO2)
Cerebral fractional tissue oxygen extraction (CFTOE), calculated as (oxygen saturation \[SpO2\] - CrSO2) / SpO2, will be calculated offline
Newborn Infant Parasympathetic Evaluation (NIPE) index
Measurement of heart rate variability
Diaphragmatic thickness
Measurement of Diaphragmatic thickness (DT) using lung ultrasound
Sponsors and contacts
Click on the lead sponsor to view all of their trials.